15,000 second chances: Bone Marrow Transplant program celebrates new milestone

April 24, 2019 | Michael Easterling and Samantha Bonar

City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.

Continue Reading

Combined immunotherapy could tackle advanced cancers

April 15, 2019 | Zen Vuong

City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearly impossible-to-treat cancer into a disease that can be corralled into remission.

Def Leppard guitarist defies cancer diagnosis

March 29, 2019 | Samantha Bonar

Def Leppard guitarist Vivian Campbell was diagnosed with Hodgkin's lymphoma in 2013. After chemotherapy and a stem cell transplant failed, immunotherapy has kept his cancer at bay for the last four years.

New Immunotherapy for Colon Cancer Answers a Patient's Prayer

December 24, 2018 | Maxine Nunes

After a CAT scan found a suspicious spot, a colonoscopy showed that Quiana Godinez had colon cancer. Godinez was put on the breakthrough immunotherapy drug Keytruda (pembrolizumab), which had just received FDA approval for certain types of cancers, including hers.

New hormone and immunotherapy trial for breast cancer patients

October 8, 2018 | City of Hope

This phase 2 trial studies the side effects and how well pembrolizumab and enobosarm work in treating patients with androgen receptor positive triple-negative breast cancer that has spread to other places in the body.

Live from ASCO: Immunotherapy Is a Revolution in Medicine

June 5, 2017 | Cary A. Presant, M.D.

Here at ASCO 2017 in Chicago, we’ve been hearing about promising new clinical trials that have shown that immunotherapy can control some of the most resistant cancers.